| Quarterly Financials | Mar 2015 | Jun 2015 | Sept 2015 | Dec 2015 | Mar 2016 | Jun 2016 | Sept 2016 | Dec 2016 | Mar 2017 | Jun 2017 | Sept 2017 | Dec 2017 | Mar 2018 | Jun 2018 | Sept 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sept 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sept 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 |
Revenue  | 152 | 123 | 115 | 119 | 132 | 142 | 111 | 143 | 153 | 139 | 150 | 210 | 241 | 185 | 211 | 242 | 273 | 261 | 223 | 275 | 296 | 306 | 258 | 299 | 329 | 341 | 312 | 386 | 411 | 385 | 486 | 398 | 429 | 426 | 408 | 388 | 408 | 398 | 436 | 435 |
| Expenses | 120 | 94 | 99 | 106 | 104 | 122 | 94 | 132 | 158 | 150 | 142 | 202 | 221 | 168 | 184 | 226 | 251 | 225 | 192 | 244 | 259 | 255 | 223 | 251 | 276 | 285 | 289 | 326 | 365 | 337 | 428 | 338 | 393 | 381 | 381 | 363 | 465 | 378 | 531 | 387 |
| EBITDA | 32 | 29 | 16 | 14 | 28 | 21 | 17 | 11 | -6 | -11 | 8 | 8 | 19 | 18 | 27 | 16 | 21 | 36 | 31 | 30 | 37 | 52 | 35 | 48 | 53 | 56 | 23 | 61 | 46 | 48 | 58 | 60 | 36 | 45 | 27 | 25 | -57 | 20 | -95 | 48 |
| Operating Profit % | 17 % | 23 % | 13 % | 11 % | 21 % | 11 % | 16 % | 1 % | -5 % | -8 % | 3 % | 3 % | 5 % | 8 % | 9 % | 6 % | 6 % | 14 % | 14 % | 11 % | 12 % | 17 % | 13 % | 16 % | 15 % | 14 % | 7 % | 14 % | 6 % | 12 % | 11 % | 13 % | 8 % | 9 % | 6 % | 6 % | -16 % | 5 % | -25 % | 11 % |
| Depreciation | 5 | 4 | 4 | 4 | 5 | 5 | 6 | 6 | 6 | 5 | 6 | 6 | 10 | 7 | 8 | 7 | 7 | 8 | 8 | 8 | 9 | 10 | 10 | 13 | 12 | 13 | 13 | 13 | 16 | 14 | 14 | 16 | 18 | 19 | 19 | 21 | 20 | 20 | 21 | 15 |
| Interest | 7 | 6 | 6 | 6 | 7 | 7 | 6 | 9 | 5 | 6 | 8 | 10 | 4 | 9 | 10 | 11 | 7 | 6 | 14 | 8 | 15 | 11 | 8 | 7 | 12 | 10 | 9 | 7 | 10 | 19 | 19 | 12 | 10 | 10 | 20 | 14 | 16 | 23 | 26 | 34 |
| Profit Before Tax | 20 | 20 | 8 | 5 | 17 | 9 | 6 | -3 | -17 | -22 | -6 | -8 | 5 | 2 | 10 | -2 | 7 | 23 | 9 | 14 | 13 | 32 | 17 | 28 | 29 | 33 | 1 | 41 | 20 | 15 | 26 | 32 | 8 | 16 | -12 | -10 | -94 | -24 | -142 | -0 |
| Tax | -3 | 6 | 3 | 2 | 3 | 6 | 5 | 0 | -12 | -10 | -3 | -3 | 10 | 6 | 8 | -1 | 0 | 6 | 1 | 10 | 11 | 11 | 8 | 8 | 13 | 9 | 5 | 14 | 7 | 11 | 16 | 9 | 5 | 4 | 9 | 5 | -12 | 11 | -26 | 7 |
| Net Profit | 23 | 14 | 5 | 3 | 14 | 3 | 1 | -4 | -5 | -11 | -3 | -5 | -4 | -4 | 2 | -1 | 6 | 16 | 8 | 4 | 2 | 21 | 10 | 19 | 16 | 24 | -4 | 27 | 13 | 4 | 10 | 23 | 4 | 12 | -21 | -14 | -82 | -35 | -116 | -8 |
| EPS in ₹ | 0.47 | 1.45 | 0.53 | 0.27 | 1.48 | 0.12 | 0.07 | -0.33 | -0.85 | -1.16 | -0.40 | -1.36 | -0.66 | -0.49 | 0.11 | -0.17 | 0.60 | 1.28 | 0.57 | 0.43 | 0.22 | 1.27 | 0.49 | 1.26 | 1.16 | 1.75 | -0.43 | 2.25 | 1.16 | 0.37 | 0.83 | 1.53 | 0.59 | 0.96 | -1.17 | -0.71 | -4.64 | -2.03 | -5.98 | -0.24 |
Camlin Fine Sciences
169.28
-4.28
(-2.47%)
There are new updates from the company4 hours ago
View
Market Cap
3,181.13 Cr
EPS
-5.58
PE Ratio
-
Dividend Yield
0.00 %
Industry
Chemicals52 Week High
180.86
52 Week Low
78.11
PB Ratio
3.74
Debt to Equity
0.94
Sector
Specialty Chemicals
Live Chart 
Investment Returns
In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Analyst Rating
- By Refinitiv from2 analysts
Peer Comparison Compare Peers on Screener
| Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
| 2,823.05 | 1,43,593.32 | 71.63 | 12,522.60 | 5.69 | 1,747 | 9.04 | 57.81 | |
| 2,945.65 | 87,316.38 | 77.33 | 13,221.50 | -11.53 | 1,336 | 6.99 | 56.46 | |
| 3,985.20 | 43,777.42 | 96.01 | 4,387.70 | -25.09 | 435 | 57.50 | 63.09 | |
| 2,037.50 | 27,790.08 | 41.36 | 7,757.90 | -3.26 | 811 | -51.46 | 50.21 | |
| 432.85 | 21,368.99 | 43.86 | 4,227.40 | 0.66 | 411 | 29.69 | 48.56 | |
| 4,206.45 | 20,852.60 | 78.83 | 2,120.90 | 0.37 | 271 | 7.18 | 59.81 | |
| 4,430.10 | 19,175.97 | 32.22 | 13,843.30 | - | 563 | -26.05 | 43.43 | |
| 5,809.45 | 17,104.04 | 42.46 | 4,783.90 | -13.69 | 324 | 62.41 | 51.94 | |
| 1,605.55 | 16,644.04 | 42.69 | 1,938.80 | -8.77 | 323 | 21.85 | 50.85 | |
| 397.90 | 14,424.64 | 40.56 | 6,380.70 | -3.61 | 417 | -62.90 | 46.14 |
Growth Rate
Revenue Growth
-3.48 %
Net Income Growth
-363.57 %
Cash Flow Change
173.05 %
ROE
-353.42 %
ROCE
-129.11 %
EBITDA Margin (Avg.)
-56.12 %
Quarterly Financial Results
Balance Sheet
| Balance Sheet | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
| Total Assets | 430 | 483 | 673 | 1,017 | 1,087 | 1,234 | 1,482 | 1,800 | 2,060 | 1,952 |
| Fixed Assets | 106 | 140 | 201 | 278 | 272 | 306 | 584 | 601 | 858 | 816 |
| Current Assets | 299 | 300 | 419 | 666 | 673 | 675 | 795 | 894 | 1,088 | 1,001 |
| Capital Work in Progress | 3 | 25 | 8 | 14 | 59 | 179 | 24 | 215 | 43 | 46 |
| Investments | 0 | 0 | 19 | 115 | 11 | 7 | 7 | 7 | 8 | 8 |
| Other Assets | 320 | 317 | 445 | 609 | 745 | 742 | 867 | 977 | 1,152 | 1,082 |
| Total Liabilities | 430 | 483 | 673 | 1,017 | 1,087 | 1,234 | 1,482 | 1,800 | 2,060 | 1,952 |
| Current Liabilities | 262 | 280 | 386 | 471 | 460 | 548 | 478 | 595 | 793 | 732 |
| Non Current Liabilities | 33 | 27 | 57 | 112 | 196 | 226 | 291 | 440 | 443 | 363 |
| Total Equity | 135 | 176 | 230 | 433 | 430 | 460 | 713 | 765 | 824 | 857 |
| Reserve & Surplus | 125 | 167 | 202 | 359 | 355 | 388 | 582 | 729 | 800 | 845 |
| Share Capital | 10 | 10 | 10 | 12 | 12 | 12 | 13 | 16 | 16 | 17 |
Cash Flow
| Cash Flow | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
| Net Cash Flow | 5 | -1 | 13 | 18 | 15 | -1 | 23 | 32 | -14 | -14 |
| Investing Activities | -26 | -66 | -70 | -149 | -2 | -90 | -133 | -249 | -125 | -67 |
| Operating Activities | 46 | 72 | -9 | -15 | -9 | 86 | 117 | 145 | 51 | 139 |
| Financing Activities | -16 | -7 | 91 | 182 | 26 | 3 | 39 | 136 | 60 | -86 |
Share Holding
| % Holding | Sept 2016 | Dec 2016 | Mar 2017 | Jun 2017 | Sept 2017 | Dec 2017 | Mar 2018 | Jun 2018 | Sept 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sept 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sept 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Jan 2025 |
| Promoter | 41.14 % | 41.14 % | 40.95 % | 40.96 % | 40.93 % | 35.06 % | 22.37 % | 22.39 % | 22.49 % | 22.66 % | 22.66 % | 22.66 % | 22.70 % | 22.85 % | 22.85 % | 22.85 % | 22.84 % | 21.74 % | 21.73 % | 21.71 % | 21.71 % | 21.71 % | 17.65 % | 17.64 % | 17.64 % | 17.64 % | 17.64 % | 16.52 % | 48.03 % | 48.03 % | 48.03 % | 48.02 % | 48.02 % | 48.02 % | 49.10 % |
| FIIs | 8.75 % | 7.00 % | 7.56 % | 7.76 % | 2.54 % | 2.29 % | 4.73 % | 4.26 % | 1.30 % | 1.37 % | 1.25 % | 1.12 % | 0.93 % | 0.89 % | 1.22 % | 1.16 % | 1.75 % | 1.71 % | 4.71 % | 5.28 % | 5.01 % | 4.81 % | 10.50 % | 10.74 % | 11.32 % | 10.94 % | 10.18 % | 0.00 % | 0.00 % | 0.00 % | 1.69 % | 1.01 % | 0.81 % | 0.76 % | 0.82 % |
| DIIs | 2.81 % | 3.42 % | 4.69 % | 5.02 % | 6.72 % | 16.82 % | 18.49 % | 19.25 % | 19.97 % | 19.04 % | 19.02 % | 19.13 % | 21.23 % | 21.41 % | 21.06 % | 18.97 % | 18.99 % | 20.34 % | 20.21 % | 19.71 % | 19.03 % | 17.88 % | 14.47 % | 14.20 % | 13.53 % | 12.53 % | 12.33 % | 9.31 % | 2.74 % | 2.75 % | 4.54 % | 4.89 % | 4.24 % | 3.39 % | 4.09 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.40 % | 0.40 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.01 % | 0.03 % | 0.03 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 29.94 % | 28.56 % | 28.28 % | 27.57 % | 28.29 % | 26.07 % | 30.94 % | 31.32 % | 33.29 % | 34.51 % | 34.76 % | 35.09 % | 36.61 % | 34.30 % | 34.45 % | 35.65 % | 35.89 % | 33.57 % | 31.21 % | 35.11 % | 35.68 % | 36.69 % | 30.32 % | 30.77 % | 30.32 % | 31.31 % | 31.30 % | 30.41 % | 33.23 % | 34.18 % | 32.75 % | 33.89 % | 34.52 % | 35.13 % | 33.14 % |
| Others | 17.36 % | 19.88 % | 18.52 % | 18.69 % | 21.53 % | 19.36 % | 23.07 % | 22.78 % | 22.95 % | 22.42 % | 22.30 % | 22.00 % | 18.53 % | 20.56 % | 20.42 % | 21.37 % | 20.53 % | 22.65 % | 22.14 % | 18.18 % | 18.56 % | 18.91 % | 27.05 % | 26.65 % | 27.19 % | 27.57 % | 28.51 % | 43.72 % | 16.00 % | 15.04 % | 12.99 % | 12.19 % | 12.41 % | 12.70 % | 12.85 % |
| No of Share Holders | 30,639 | 28,337 | 29,209 | 29,101 | 29,767 | 26,478 | 31,972 | 34,096 | 36,498 | 36,717 | 35,885 | 35,285 | 33,154 | 33,849 | 41,630 | 43,139 | 39,500 | 40,599 | 38,712 | 41,543 | 51,038 | 56,394 | 55,277 | 57,835 | 57,904 | 54,197 | 52,921 | 52,278 | 57,098 | 62,098 | 58,165 | 62,687 | 67,750 | 61,893 | 60,554 |
Dividend History
Dividends per share (FY)
Dividend yield (FY) %
| Annual Cash Flows | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Per Share (₹) | 0.45 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend Yield (%) | 0.51 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Corporate Action
Login to View
This information is available only for users of ScanX and Dhan.To proceed ahead,
LoginOpen Account
Announcements
Announcement under Regulation 30 (LODR)-Newspaper Publication
Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
Update On Analyst / Institutional Investor Meeting
Update On Joint Press Release
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Announcement under Regulation 30 (LODR)-Change in Management
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Update On Press Release
Update On Press Release
Disclosure Pursuant To Clause 5 Of Para B Of Part A Of Schedule III Of SEBI LODR Regulations 2015
Announcement under Regulation 30 (LODR)-Acquisition
Announcement under Regulation 30 (LODR)-Investor Presentation
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Announcement under Regulation 30 (LODR)-Newspaper Publication
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Integrated Filing (Financial)
Announcement under Regulation 30 (LODR)-Investor Presentation
Board Meeting Outcome for Unaudited Financial Results (Standalone And Consolidated) Of The Company For The Quarter And
Nine Months Ended December 31 2024
Unaudited Financial Results (Standalone And Consolidated) Of The Company For The Quarter And Nine Months Ended December 31 2024
Announcement under Regulation 30 (LODR)-Newspaper Publication
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Announcement under Regulation 30 (LODR)-Change in Management
Board Meeting Intimation for Intimation About The Board Meeting Of Camlin Fine Sciences Limited (The Company) To Be Held On February 14 2025
Regulation 30 And Schedule III Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 (Listing Regulations): Intimation Regarding Receipt Of An Order From Office Of The Asst./D
Announcement under Regulation 30 (LODR)-Change in Management
Regulation 30 And Schedule III Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 (Listing Regulations): Update On Intimation Made Regarding Receipt Of Closure Direction Fo
Regulation 30 And Schedule III Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 (Listing Regulations): Intimation Regarding Receipt Of An Order From Office Of The Commiss
Announcement under Regulation 30 (LODR)-Allotment
Board Meeting Outcome for Outcome Of The Meeting Of The Securities Issue And Allotment Committee Of The Board Of
Directors Of Camlin Fine Sciences Limited
Clarification
Announcement under Regulation 30 (LODR)-Newspaper Publication
Announcement under Regulation 30 (LODR)-Strikes /Lockouts / Disturbances
Intimation Regarding Receipt Of Closure Direction For Our Unit Situated At SEZ Dahej Bharuch.
Announcement under Regulation 30 (LODR)-Newspaper Publication
Regulation 30 And Schedule III Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 (Listing Regulations): Intimation Regarding Receipt Of An Order From Office Of The Commiss
Board Meeting Outcome for Outcome Of The Meeting Of The Securities Issue And Allotment Committee Of The Board Of Directors Of Camlin Fine Sciences Limited (The Company) Held On January 9 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
Intimation Regarding Change In The Name Of Registrar And Share Transfer Agent (RTA) Of Camlin Fine Sciences Limited (The Company).
Rights Issue - Record Date Is Wednesday January 8 2025
Announcement under Regulation 30 (LODR)-Raising of Funds
Board Meeting Outcome for Outcome Of The Meeting Of The Securities Issue And Allotment Committee Of The Board Of Directors Of Camlin Fine Sciences Limited (The Company) Held On January 2 2025.
Board Meeting Intimation for Intimation Of The Meeting Of The Securities Issue And Allotment Committee Of The Board Of Directors To Be Held On Thursday January 2 2025.
Announcement under Regulation 30 (LODR)-Change in Management
Update For An Announcement Made Under Regulation 30 (LODR)-Change In Management Dated November 11, 2024
Disclosures under Reg. 10(6) of SEBI (SAST) Regulations, 2011
Announcement under Regulation 30 (LODR)-Allotment
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Announcement under Regulation 30 (LODR)-Issue of Securities
Board Meeting Outcome for The Revision Of The Quantum Of The Proposed Rights Issue To An Amount Not Exceeding Rs. 225 Crores And Proposal For Fund Raising By Way Of Issuance Of Non-Convertible Debentures Aggregating For An Amount Of Rs. 100 Crores On A Private Placement Basis.
Board Meeting Intimation for The Revision Of The Quantum Of The Proposed Rights Issue To An Amount Not Exceeding Rs. 225 Crores; And Issue Of Any Debt Securities Of The Company.
Technical Indicators
RSI(14)
Neutral 62.90
ATR(14)
Volatile 8.65
STOCH(9,6)
Neutral 72.83
STOCH RSI(14)
Neutral 43.99
MACD(12,26)
Bearish -0.01
ADX(14)
Strong Trend 40.64
UO(9)
Bearish 55.95
ROC(12)
Uptrend But Slowing Down 2.97
WillR(14)
Neutral -22.36
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
